| # | Title | Journal | Year | Citations |
|---|
| 1 | Overcoming Multidrug Resistance in Cancer: An Update on the Clinical Strategy of Inhibiting P-Glycoprotein | Cancer Control | 2003 | 827 |
| 2 | Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma | Cancer Control | 2017 | 400 |
| 3 | Barriers to Clinical Trial Enrollment in Racial and Ethnic Minority Patients with Cancer | Cancer Control | 2016 | 303 |
| 4 | Solitary Fibrous Tumor of the Pleura | Cancer Control | 2006 | 291 |
| 5 | Bortezomib (PS-341): A Novel, First-in-Class Proteasome Inhibitor for the Treatment of Multiple Myeloma and Other Cancers | Cancer Control | 2003 | 269 |
| 6 | The Molecular Biology of Endometrial Cancers and the Implications for Pathogenesis, Classification, and Targeted Therapies | Cancer Control | 2009 | 264 |
| 7 | EGFR Targeting of Solid Tumors | Cancer Control | 2007 | 245 |
| 8 | Clinical Experience with Angiogenesis Signaling Inhibitors: Focus on Vascular Endothelial Growth Factor (VEGF) Blockers | Cancer Control | 2002 | 236 |
| 9 | Endometrial Cancer and Lynch Syndrome: Clinical and Pathologic Considerations | Cancer Control | 2009 | 220 |
| 10 | Teachable Moments for Promoting Smoking Cessation: The Context of Cancer Care and Survivorship | Cancer Control | 2003 | 217 |
| 11 | Cancer Incidence among Korean-American Immigrants in the United States and Native Koreans in South Korea | Cancer Control | 2007 | 210 |
| 12 | Celecoxib: A Specific COX-2 Inhibitor with Anticancer Properties | Cancer Control | 2002 | 207 |
| 13 | Mechanisms of Primary and Secondary Resistance to Imatinib in Chronic Myeloid Leukemia | Cancer Control | 2009 | 207 |
| 14 | Intraocular Lymphoma: Update on Diagnosis and Management | Cancer Control | 2004 | 201 |
| 15 | A Review of Triple-Negative Breast Cancer | Cancer Control | 2010 | 197 |
| 16 | Liver Resection and Surgical Strategies for Management of Primary Liver Cancer | Cancer Control | 2018 | 182 |
| 17 | Interaction between Comorbidity and Cancer | Cancer Control | 2007 | 180 |
| 18 | Rosai-Dorfman Disease: Tumor Biology, Clinical Features, Pathology, and Treatment | Cancer Control | 2014 | 179 |
| 19 | Poorly Differentiated and Anaplastic Thyroid Cancer | Cancer Control | 2006 | 177 |
| 20 | Malignant Pleural Mesothelioma: A Comprehensive Review | Cancer Control | 2006 | 175 |
| 21 | Yoga for Cancer Patients and Survivors | Cancer Control | 2005 | 174 |
| 22 | Aging, Frailty, and Chemotherapy | Cancer Control | 2007 | 169 |
| 23 | Diagnosis, Classification, and Management of Soft Tissue Sarcomas | Cancer Control | 2005 | 168 |
| 24 | Epistemologic Inquiries in Evidence-Based Medicine | Cancer Control | 2009 | 164 |
| 25 | Lessons Learned from Community-Based Participatory Research in Indian Country | Cancer Control | 2005 | 163 |
| 26 | Interventional Treatment of Cancer Pain: The Fourth Step in the World Health Organization Analgesic Ladder? | Cancer Control | 2000 | 155 |
| 27 | Diagnosis and Management of Retinoblastoma | Cancer Control | 2004 | 150 |
| 28 | Prognostication of Survival in Patients with Advanced Cancer: Predicting the Unpredictable? | Cancer Control | 2015 | 147 |
| 29 | Spectrum of Activity and Mechanism of Action of VEGF/PDGF Inhibitors | Cancer Control | 2007 | 145 |
| 30 | Prognostic Indicators in Differentiated Thyroid Carcinoma | Cancer Control | 2000 | 144 |
| 31 | Nucleotide Excision Repair Pathways Involved in Cisplatin Resistance in Non-Small-Cell Lung Cancer | Cancer Control | 2003 | 143 |
| 32 | Chemotherapy-Induced Amenorrhea and Fertility in Women Undergoing Adjuvant Treatment for Breast Cancer | Cancer Control | 2002 | 141 |
| 33 | Selective Hepatic Artery Embolization for Treatment of Patients with Metastatic Carcinoid and Pancreatic Endocrine Tumors | Cancer Control | 2006 | 140 |
| 34 | Comprehensive Geriatric Assessment | Cancer Control | 2003 | 135 |
| 35 | Lung Cancer Screening: Advantages, Controversies, and Applications | Cancer Control | 2014 | 131 |
| 36 | Diagnosis and Treatment of mela-noma Brain Metastasis: A Literature Review | Cancer Control | 2009 | 130 |
| 37 | Molecular Prognostic Markers in Pancreatic Cancer | Cancer Control | 2000 | 128 |
| 38 | PD-1 Pathway Inhibitors: Changing the Landscape of Cancer Immunotherapy | Cancer Control | 2014 | 127 |
| 39 | Diagnosis and Management of Castleman Disease | Cancer Control | 2014 | 127 |
| 40 | Lymphangioleiomyomatosis | Cancer Control | 2006 | 125 |
| 41 | The New Melanoma Staging System | Cancer Control | 2002 | 123 |
| 42 | Participation of the Elderly Population in Clinical Trials: Barriers and Solutions | Cancer Control | 2014 | 120 |
| 43 | Tracheobronchial Gland Tumors | Cancer Control | 2006 | 119 |
| 44 | Non-Endometrioid Adenocarcinoma of the Uterine Corpus: A Review of Selected Histological Subtypes | Cancer Control | 2009 | 118 |
| 45 | Separation Surgery for Spinal Metastases: Effect of Spinal Radiosurgery on Surgical Treatment Goals | Cancer Control | 2014 | 117 |
| 46 | The Collaborative Ocular Melanoma Study: An Overview | Cancer Control | 2004 | 114 |
| 47 | Orthopedic Surgery Options for the Treatment of Primary Osteosarcoma | Cancer Control | 2008 | 111 |
| 48 | Modulation of Brain Tumor Capillaries for Enhanced Drug Delivery Selectively to Brain Tumor | Cancer Control | 2004 | 109 |
| 49 | Critical Evaluation of Chemical Neurolysis of the Sympathetic Axis for Cancer Pain | Cancer Control | 2000 | 108 |
| 50 | Race Disparities between Black and White Women in the Incidence, Treatment, and Prognosis of Endometrial Cancer | Cancer Control | 2009 | 107 |
